Markets

Insider Trading

Hedge Funds

Retirement

Opinion

The City with the Lowest Life Expectancy in the World

We recently compiled a list of the 30 Cities with the Lowest Life Expectancy in the World. But in this article, we will focus on the city with the lowest life expectancy in the world and take an overview of the trends in life expectancy across the globe.

Trends in Global Life Expectancy Across the Globe

Global life expectancy has increased dramatically over the years: it stood at just 51 years in 1960, rising to around 71 years in the present decade. Data by the World Health Organization reveals that global life expectancy increased by more than six years between 2000 and 2019 before the pandemic, going from 66.8 years in 2000 to 73.1 years in 2019. Healthy life expectancy (HALE), also grew by 9%, increasing from 58.1 in 2000 to 63.5 in 2019. This increase was primarily due to a decline in mortality instead of a decrease in the number of years people lived with disability. The increase in life expectancy thus surpassed the rise in HALE, at 6.4 years and 5.3 years, respectively.

However, the COVID-19 pandemic reversed around a decade of life expectancy and HALE increase. According to the World Health Statistics 2024 report by the World Health Organization (WHO),  global life expectancy and HALE in 2020 returned to their 2016 levels at 72.5 years and 62.8 years, respectively. 2021 saw a further recession, with the two metrics returning to their 2012 levels. Global life expectancy reduced to 71.4 years, while HALE decreased to 61.9 years. The pandemic thus wiped out a decade of improvement in just two years.

The report also highlighted the unequal effects of these trends across the globe, with WHO regions for Southeast Asia and the Americas suffering the most. Life expectancy in the regions fell by around three years, with healthy life expectancy dropping by 2.5 years between 2019 and 2022. The Western Pacific Region, in contrast, remained minimally affected, experiencing a drop of less than 0.1 years in life expectancy and 0.2 years in healthy life expectancy between 2019 and 2021. You can also look at 15 Countries with the Highest Life Expectancy in Asia for more insight.

Life expectancy in the US underwent a similar decline due to the pandemic. According to the Centers for Disease Control and Prevention, life expectancy for both sexes in the country stands at 77.5 years as of 2022, with 74.8 years for males and 80.2 years for women.

Role of Healthcare and Pharmaceuticals in Managing Life Expectancy

With almost all facets of life returning to normal after the pandemic, global life expectancy is also expected to revert to its pre-pandemic levels. In fact, a study by the Global Burden of Disease forecasted an increase of 4.9 years in the global life expectancy of males and 4.2 years in that of females between 2022 and 2050. These life expectancy increases are anticipated to be the most significant in countries with low life expectancies, allowing a confluence of increasing life expectancies across the globe.

These trends are primarily driven by extensive public health measures that have improved and prevented survival rates from COVID-19, cardiovascular diseases, and several communicable, maternal, neonatal, and nutritional diseases (CMNNs). Overall, almost all countries worldwide are expected to experience an improvement in their average life expectancies, driven by upgrading healthcare and infrastructure. Increased availability of facilities and higher access to nutritional food are also pivotal factors in the domain. Prominent healthcare and pharmaceutical companies are playing their roles in bringing life expectancy back to pre-pandemic levels by introducing advanced treatments and medications to combat death and diseases. Johnson & Johnson (NYSE:JNJ) is a significant player in the field. Headquartered in New Jerse, this multinational pharmaceutical, medical technologies, and biotechnology corporation holds expertise in Innovative Medicine and MedTech domains and operates under several business units, including DePuy Synthes, Neutrogena Corporation, Ethicon, Janssen Pharmaceuticals, and Acclarent.

On August 2nd, DePuy Synthes, which is the Orthopaedics Company of Johnson & Johnson (NYSE:JNJ), announced the launch of VELYS™ Active Robotic-Assisted System, also known as VELYS™ SPINE. Developed in collaboration with eCential Robotics, this dual-use robotics and standalone navigation platform is one of a kind, allowing surgeons to tackle the most complex challenges with its active robotics technology. The platform will be used in planning and instrumenting spinal fusion procedures in the thoracolumbar, cervical, and sacroiliac spine. The company’s continued digital advancements in the field of surgical robotics and navigation have established it as a leader in the domain.

Johnson & Johnson (NYSE:JNJ) is also seeking FDA approval for the first and only monotherapy available for adults with treatment-resistant depression: SPRAVATO®(esketamine). Results from the fourth phase of SPRAVATO® monotherapy data show quick improvement in depression symptoms, building on more than a decade of clinical trials and research. This monotherapy nasal spray will allow patients living with treatment-resistant depression, preventing them from jumping from one treatment to another that fail to curb their symptoms. The Johnson & Johnson (NYSE:JNJ) MedTech unit supports technology that is applied in approximately 75 million medical procedures every year, and announced plans in March to collaborate with Nvidia (NASDAQ:NVDA) to develop new artificial intelligence applications for surgery. The companies plan to employ Artificial Intelligence within surgical platforms and devices to help surgeons from pre-op to post-op, automating and streamlining the procedures.

Now that we have taken an overview of the trends in life expectancy around the globe, let’s look at the citiy with the lowest life expectancy in the world. You can also look at 20 US Cities With the Shortest Life Expectancy and 15 Countries with the Highest Life Expectancy in Africa.

Pixabay/Public Domain

Our Methodology

To compile a list of the 30 cities with the lowest life expectancy in the world, we considered the Central Intelligence Agency’s (CIA) list of average life expectancy of countries across the globe. We shortlisted the 30 countries with the lowest life expectancy in the world, and used that as a proxy for the life expectancies of their largest cities. The 30 cities with the lowest life expectancy in the world are arranged in descending order of their average life expectancy as of 2024.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

The City with the Lowest Life Expectancy in the World

1. Kabul, Afghanistan

Average Life Expectancy as of 2024:  54.4 Years 

Kabul ranks first on our list of the 30 cities with the lowest life expectancy in the world. It is the capital and largest city of Afghanistan, a landlocked country located at the connecting point of South Asia and Central Asia. Afghanistan has been suffering from decades of war, inadequate administrative practices, and failing infrastructure, which are some of the primary reasons behind the country’s low life expectancy. Kabul is located in the eastern half of the country and forms a part of the Kabul Province as a municipality. It is divided into 22 municipal districts for administration and houses around 4.95 million people as of 2023. The city has an average life expectancy of around 54.4 years as of 2024, the lowest in the world.

If you are interested in learning about other cities with the lowest life expectancy in the world, take a look at our detailed report on 30 Cities with the Lowest Life Expectancy in the World.

At Insider Monkey, we delve into a variety of topics; however, our expertise lies in identifying the top-performing stocks. Currently, Artificial Intelligence (AI) technology stands out as one of the most promising fields. If you are looking for an AI stock that is more promising than NVDA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and Jim Cramer is Recommending These 10 Stocks in June.

Disclosure: None. This article is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
  • One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
  • Bonus Reports: Premium access to members-only fund manager video interviews
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…